Clinical Trial Update: Casein Glycomacropeptide in Active Distal Ulcerative Colitis (Pilot Study) [NA]

View source ↗

Summary

A pilot clinical trial evaluating casein glycomacropeptide for active distal ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Casein glycomacropeptide (casein glycomacropeptide)

Snippet

Sponsor: University of Aarhus | Conditions: Colitis, Ulcerative, Inflammatory Bowel Diseases | NA | Status: COMPLETED